Articles published by Revance Therapeutics, Inc.
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
RVNC
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
RVNC
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Revance to Participate in Upcoming Investor Conferences
March 07, 2023
Via Business Wire
Tickers
RVNC
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Revance Reports Fourth Quarter and Full Year 2022 Financial Results, Provides Corporate Update
February 28, 2023
Via Business Wire
Tickers
RVNC
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Revance to Participate in the 43rd Annual Cowen Healthcare Conference
February 27, 2023
Via Business Wire
Tickers
RVNC
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Revance to Release Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 28, 2023
February 21, 2023
Via Business Wire
Tickers
RVNC
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
RVNC
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Revance to Participate in the Stifel 2022 Healthcare Conference
November 09, 2022
Via Business Wire
Tickers
RVNC
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
RVNC
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Revance to Release Third Quarter 2022 Financial Results on Tuesday, November 8, 2022
November 01, 2022
Via Business Wire
Tickers
RVNC
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
RVNC
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Revance to Participate in the Guggenheim Nantucket Therapeutics Conference
September 21, 2022
Via Business Wire
Tickers
RVNC
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
RVNC
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Revance Announces Pricing of $200.0 Million Upsized Public Offering of Common Stock
September 12, 2022
Via Business Wire
Tickers
RVNC
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Revance Announces Proposed Public Offering of Common Stock
September 12, 2022
Via Business Wire
Tickers
RVNC
![](https://mms.businesswire.com/media/20220908005320/en/1565360/5/Product_Shot_2_DAXXIFY%E2%84%A2_%28daxibotulinumtoxinA-lanm%29_for_injection.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
RVNC
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
RVNC
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
RVNC
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
RVNC
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.